InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,048.42
(
-0.46%
)
US TECH 100
17,144.40
(
0.98%
)
Dow Jones
38,085.80
(
-0.98%
)
Brent Oil
88.47
(
0.36%
)
Bitcoin
64,239.28
(
-0.38%
)
Post# of 20775
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

montanus

Send PM Follow Ignore
Followers 13
Posts 1001
Boards Moderated 0
Alias Born 03/12/2009

montanus

Re: Stately post# 20440

Thursday, 06/29/2017 8:28:46 AM

Thursday, June 29, 2017 8:28:46 AM

Post# of 20775
Yes and the agreement for a FA treatment with shire was terminated by Maza in april. indole-3-propionic acid alias OX1 alias SHP622 was tested in a 1a, 1b and a phase 1 clinical trial and it was safe and well tolerated. It may be a treatment for other diseases like diabetes as reported. I guess there was a good reason for the termination in april and if you look at IMNP (CEO Maza) and their contacts and recently initiated clincal trials in scandinavia - read through the lines....

TauC3 is well known and HOT but don't forget the other ILNS options

ALL IMO

Things that are equal to the same thing are also equal to one another (Transitive property of equality). If equals are added to equals, then the wholes are equal. If equals are subtracted from equals, then the remainders are equal. Things that coincide wi

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up